Focal Point |

Vaccine Research in Asia

Looking to the east

Asia is shaping up to be a vaccine powerhouse. The signs are there in funding levels, and combined with Asian governments’ interest in biotechnology, and a highly skilled, highly educated workforce, pharma giants are looking east.

This advertisement feature is produced by Nature Research Custom Media in partnership with the National Institute of Biomedical Innovation, Health and Nutrition (NIBIOHN). The advertiser retains responsibility for content. About this content.

Focal Point feature

Partner content

Integrating basic and clinical research is key to the development of safe and effective mucosal vaccines taken orally or nasally, says Hiroshi Kiyono of the Institute of Medical Science, the University of Tokyo.

Advertisement Feature |

Chiba University's partnership with the University of California San Diego is advancing immunology research and education in a big way.

Advertisement Feature |

KM Biologics’ research roots help it successfully innovate in the field of vaccine development.

Advertisement Feature |

From tuberculosis and pneumonia, to Ebola and Zika, a Chinese biotech firm is developing high-quality vaccines to address global health challenges.

Advertisement Feature |